Carleen McQuaid
Family Medicine · Charlton, MANPI 1780895433
Payments from drug & device makers
Across 252 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$902
- AbbVie$738
- AstraZeneca$392
- Pfizer$390
- Novo Nordisk$373
- Boehringer Ingelheim$269
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 41 | $902 |
| AbbVie | 37 | $738 |
| AstraZeneca | 21 | $392 |
| Pfizer | 19 | $390 |
| Novo Nordisk | 19 | $373 |
| Boehringer Ingelheim | 14 | $269 |
| Amgen | 14 | $215 |
| Abbott | 9 | $185 |
| Bristol Myers Squibb | 7 | $157 |
| Ardelyx, Inc. | 6 | $132 |
| Teva Pharmaceuticals USA, Inc. | 12 | $122 |
| GSK | 7 | $121 |
| Exact Sciences | 4 | $107 |
| Amarin Pharma, Inc. | 5 | $98 |
| Astellas Pharma US Inc | 3 | $93 |
| Johnson & Johnson | 5 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Biohaven Pharmaceuticals, Inc. | 2 | $57 |
| Bayer | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,950 in reported general payments places this provider in the 90th percentile of 1,049 family medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 13 | $57,643 |
| TrulicityDulaglutide | 49 | $46,855 |
| EliquisApixaban | 31 | $33,374 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $19,705 |
| OzempicSemaglutide | 12 | $13,623 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $6,385 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,239 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,884 |
| Arnuity ElliptaFluticasone Furoate | 14 | $4,729 |
| Xtampza ErOxycodone Myristate | 11 | $4,281 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $2,481 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $2,039 |
| Atorvastatin Calcium | 130 | $1,456 |
| Duloxetine Hcl | 18 | $1,147 |
| Losartan Potassium | 129 | $1,125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $902 | $46,85549 claims |
| PfizerEliquis | $390 | $33,37431 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $121 | $29,31849 claims |
| Novo NordiskOzempic | $373 | $13,62312 claims |
| AbbVieSynthroid | $738 | $66817 claims |
| Almatica Pharma LLCSertraline Hcl | $18 | $36863 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,049 family medicine providers in Massachusetts.
Other family medicine in Charlton
- Paul HarringtonCharlton$8K
- Robert BeckWestford$2.1M
- Katherine Gergen BarnettBoston$226K
- Peter O'DwyerBoston$163K
- Kelly LannuttiWeymouth$122K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.